Bharat Immunologicals & Biologicals (BOM:524663) Other Net Income (Loss) : ₹-0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Other Net Income (Loss)?

Bharat Immunologicals & Biologicals's Other Net Income (Loss) for the three months ended in Sep. 2023 was ₹0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-0.00 Mil.

Bharat Immunologicals & Biologicals's quarterly Other Net Income (Loss) increased from Mar. 2023 (₹-0.00 Mil) to Jun. 2023 (₹0.00 Mil) but then stayed the same from Jun. 2023 (₹0.00 Mil) to Sep. 2023 (₹0.00 Mil).

Bharat Immunologicals & Biologicals's annual Other Net Income (Loss) declined from Mar. 2021 (₹0.00 Mil) to Mar. 2022 (₹0.00 Mil) but then stayed the same from Mar. 2022 (₹0.00 Mil) to Mar. 2023 (₹0.00 Mil).

Bharat Immunologicals & Biologicals Other Net Income (Loss) Historical Data

The historical data trend for Bharat Immunologicals & Biologicals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bharat Immunologicals & Biologicals Other Net Income (Loss) Chart

Bharat Immunologicals & Biologicals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Net Income (Loss)

Get a 7-Day Free Trial

Bharat Immunologicals & Biologicals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Bharat Immunologicals & Biologicals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.00 Mil.

Bharat Immunologicals & Biologicals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203

Website

http://www.bibcol.sciencecentral.in

Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines